Loading clinical trials...
Loading clinical trials...
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in Pediatric and Young Adult IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
Conditions
Interventions
2'-Fucosyllactose
Placebo
Locations
3
United States
Connecticut Children's Medical Center
Hartford, Connecticut, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Start Date
September 20, 2019
Primary Completion Date
June 30, 2027
Completion Date
June 30, 2027
Last Updated
June 12, 2025
NCT07550673
NCT07374471
NCT05421455
NCT06226883
NCT05739864
NCT06071312
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions